Compare AUPH & ADV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AUPH | ADV |
|---|---|---|
| Founded | 1993 | 1987 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 293.0M |
| IPO Year | 1999 | N/A |
| Metric | AUPH | ADV |
|---|---|---|
| Price | $16.28 | $0.87 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $17.25 | $2.00 |
| AVG Volume (30 Days) | ★ 1.4M | 1.1M |
| Earning Date | 11-04-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.55 | N/A |
| Revenue | $265,808,000.00 | ★ $3,502,796,000.00 |
| Revenue This Year | $21.76 | N/A |
| Revenue Next Year | $16.45 | $0.96 |
| P/E Ratio | $29.65 | ★ N/A |
| Revenue Growth | ★ 20.62 | N/A |
| 52 Week Low | $6.55 | $0.80 |
| 52 Week High | $16.51 | $3.17 |
| Indicator | AUPH | ADV |
|---|---|---|
| Relative Strength Index (RSI) | 62.41 | 39.90 |
| Support Level | $15.57 | $0.80 |
| Resistance Level | $16.07 | $0.94 |
| Average True Range (ATR) | 0.47 | 0.07 |
| MACD | -0.04 | 0.02 |
| Stochastic Oscillator | 81.46 | 32.66 |
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
Advantage Solutions Inc is a omnichannel retail solutions agency in North America, uniquely positioned at the intersection of consumer-packaged goods (CPG) brands and retailers.